These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35927287)

  • 1. Comprehensive lipid and lipid-related gene investigations of host immune responses to characterize metabolism-centric biomarkers for pulmonary tuberculosis.
    Long NP; Anh NK; Yen NTH; Phat NK; Park S; Thu VTA; Cho YS; Shin JG; Oh JY; Kim DH
    Sci Rep; 2022 Aug; 12(1):13395. PubMed ID: 35927287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive lipid profiles investigation reveals host metabolic and immune alterations during anti-tuberculosis treatment: Implications for therapeutic monitoring.
    Anh NK; Phat NK; Yen NTH; Jayanti RP; Thu VTA; Park YJ; Cho YS; Shin JG; Kim DH; Oh JY; Long NP
    Biomed Pharmacother; 2023 Feb; 158():114187. PubMed ID: 36916440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of lipid-related genes during anti-tuberculosis treatment: insights into host immune responses and potential transcriptional biomarkers.
    Phat NK; Tien NTN; Anh NK; Yen NTH; Lee YA; Trinh HKT; Le KM; Ahn S; Cho YS; Park S; Kim DH; Long NP; Shin JG
    Front Immunol; 2023; 14():1210372. PubMed ID: 38022579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
    Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
    Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of Lipid Metabolism Alterations in Children with Active Tuberculosis Using UHPLC-MS/MS.
    Sun B; Liu F; Yin Q; Jiang T; Fang M; Duan L; Quan S; Tian X; Shen A; Mi K; Sun L
    J Immunol Res; 2023; 2023():8111355. PubMed ID: 36815950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis.
    Hu X; Wang J; Ju Y; Zhang X; Qimanguli W; Li C; Yue L; Tuohetaerbaike B; Li Y; Wen H; Zhang W; Chen C; Yang Y; Wang J; Chen F
    BMC Infect Dis; 2022 Aug; 22(1):707. PubMed ID: 36008772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immune biomarkers in recent active pulmonary tuberculosis.
    Shaukat SN; Eugenin E; Nasir F; Khanani R; Kazmi SU
    Sci Rep; 2023 Jul; 13(1):11481. PubMed ID: 37460564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Host Protein Biomarkers by ELISA From Whole Lysed Peripheral Blood for Development of Diagnostic Tests for Active Tuberculosis.
    Garlant HN; Ellappan K; Hewitt M; Perumal P; Pekeleke S; Wand N; Southern J; Kumar SV; Belgode H; Abubakar I; Sinha S; Vasan S; Joseph NM; Kempsell KE
    Front Immunol; 2022; 13():854327. PubMed ID: 35720382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood transcriptomic diagnosis of pulmonary and extrapulmonary tuberculosis.
    Roe JK; Thomas N; Gil E; Best K; Tsaliki E; Morris-Jones S; Stafford S; Simpson N; Witt KD; Chain B; Miller RF; Martineau A; Noursadeghi M
    JCI Insight; 2016 Oct; 1(16):e87238. PubMed ID: 27734027
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis.
    Lee SW; Wu LS; Huang GM; Huang KY; Lee TY; Weng JT
    BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):3. PubMed ID: 26818387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction Networks.
    Sambarey A; Devaprasad A; Mohan A; Ahmed A; Nayak S; Swaminathan S; D'Souza G; Jesuraj A; Dhar C; Babu S; Vyakarnam A; Chandra N
    EBioMedicine; 2017 Feb; 15():112-126. PubMed ID: 28065665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics-based host-specific biomarkers for tuberculosis: The future of TB diagnosis.
    Pandey D; Ghosh D
    J Proteomics; 2024 Aug; 305():105245. PubMed ID: 38942234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis.
    Blankley S; Graham CM; Turner J; Berry MP; Bloom CI; Xu Z; Pascual V; Banchereau J; Chaussabel D; Breen R; Santis G; Blankenship DM; Lipman M; O'Garra A
    PLoS One; 2016; 11(10):e0162220. PubMed ID: 27706152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon.
    Essone PN; Adegbite BR; Mbadinga MJM; Mbouna AV; Lotola-Mougeni F; Alabi A; Edoa JR; Lell B; Alabi AS; Adegnika AA; Ramharter M; Siawaya JFD; Grobusch MP; Kremsner PG; Agnandji ST
    Infection; 2022 Aug; 50(4):897-905. PubMed ID: 35133607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.
    Xiao JN; Xiong Y; Chen Y; Xiao YJ; Ji P; Li Y; Wang SJ; Zhao GP; Cheng QJ; Lu SH; Wang Y
    Front Cell Infect Microbiol; 2017; 7():495. PubMed ID: 29250493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach.
    Natarajan S; Ranganathan M; Hanna LE; Tripathy S
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis Infection.
    de Araujo LS; Ribeiro-Alves M; Leal-Calvo T; Leung J; Durán V; Samir M; Talbot S; Tallam A; Mello FCQ; Geffers R; Saad MHF; Pessler F
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants.
    Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S
    Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between DNA Methylation Profiles and Active Tuberculosis Development from Latent Infection: a Pilot Study in Nested Case-Control Design.
    Du Y; Gao X; Yan J; Zhang H; Cao X; Feng B; He Y; He Y; Guo T; Xin H; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0058622. PubMed ID: 35446152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.